Form 8-K - Current report:
SEC Accession No. 0001683168-25-000009
Filing Date
2025-01-02
Accepted
2025-01-02 09:15:32
Documents
15
Period of Report
2024-12-31
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K mosaic_8k.htm   iXBRL 8-K 30941
2 TERM EXTENSION LETTER mosaic-ex1001.htm EX-10.1 7517
6 GRAPHIC image_005.jpg GRAPHIC 8868
  Complete submission text file 0001683168-25-000009.txt   219681

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE cpmv-20241231.xsd EX-101.SCH 3015
4 XBRL LABEL FILE cpmv-20241231_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE cpmv-20241231_pre.xml EX-101.PRE 22359
17 EXTRACTED XBRL INSTANCE DOCUMENT mosaic_8k_htm.xml XML 3246
Mailing Address 9114 ADAMS AVE. #202 HUNTINGTON BEACH CA 92646
Business Address 9114 ADAMS AVE. #202 HUNTINGTON BEACH CA 92646 657-208-0890
Mosaic ImmunoEngineering Inc. (Filer) CIK: 0000836564 (see all company filings)

EIN.: 841070278 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22182 | Film No.: 25500427
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)